NEW YORK, Aug. 7 - Rosetta Inpharmatics and Agilent Technologies said Tuesday that the Max Planck Institutes for Molecular Genetics, Infection Biology, and Molecular Plant Physiology would act as European demonstration sites for the Rosetta Resolver Gene Expression Data Analysis System and Agilent’s DNA Microarray Scanner. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.